TFAP4 and lymphoma: CRISPR deletion of TFAP4 in Eμ-MYC transgenic haematopoietic stem and progenitor cells (HSPCs) and transplantation of these manipulated HSPCs into lethally irradiated animals significantly accelerated c-MYC-driven lymphoma development.